DPF2 Antibody Blocking Peptide

• Reactivity: Hu
• Applications: AC
• Concentration: 0.2 mg/ml

DPF2 Antibody Blocking Peptide Summary

• Description: A blocking peptide containing 18 amino acid peptide near the carboxy terminus of human Requiem.

  Source: Synthetic

  (Accession #: AAB81203)

• Source: Synthetic
• Protein/Peptide Type: Antibody Blocking Peptide
• Gene: DPF2
• Purity: N/A

Applications/Dilutions

• Dilutions:
  • Antibody Competition
• Application Notes: This peptide is useful as a blocking peptide for NBP1-76512.
  
  For further blocking peptide related protocol, click here.

Packaging, Storage & Formulations

• Storage: Store at -20C. Avoid freeze-thaw cycles.
• Buffer: PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
• Preservative: 0.02% Sodium Azide
• Concentration: 0.2 mg/ml
• Purity: N/A

Alternate Names for DPF2 Antibody Blocking Peptide

• Apoptosis response zinc finger protein
• D4, zinc and double PHD fingers family 2BAF45D
• MGC10180
• Protein requiem
• REQBRG1-associated factor 45D
• requiem, apoptosis response zinc finger
• ubi-d4
• UBID4requiem, apoptosis response zinc finger gene
• zinc finger protein ubi-d4

Background

DPF2 is encoded by this gene is a member of the d4 domain family, characterized by a zinc finger-like structural motif. This protein functions as a transcription factor which is necessary for the apoptotic response following deprivation of survival factors. It likely serves a regulatory role in rapid hematopoietic cell growth and turnover. This gene is considered a candidate gene for multiple endocrine neoplasia type I, an inherited cancer syndrome involving multiple parathyroid, enteropancreatic, and pituitary tumors.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 3 months from date of receipt.

Bioinformatics

• Gene Symbol: DPF2